Survival benefits from adjuvant transcatheter arterial chemoembolization in patients undergoing liver resection for hepatocellular carcinoma: a systematic review and meta-analysis

BACKGROUND: Although adjuvant transcatheter arterial chemoembolization (TACE) has been used to prevent recurrence after surgery in patients with hepatocellular carcinoma (HCC), the survival benefits from adjuvant TACE remain controversial. We sought to systematically evaluate the data on the effecti...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Therap Adv Gastroenterol
Hlavní autoři: Liang, Lei, Li, Chao, Diao, Yong-Kang, Jia, Hang-Dong, Xing, Hao, Pawlik, Timothy M., Lau, Wan Yee, Shen, Feng, Huang, Dong-Sheng, Zhang, Cheng-Wu, Yang, Tian
Médium: Artigo
Jazyk:Inglês
Vydáno: SAGE Publications 2020
Témata:
Diagnosis, Management, and Prognostic Assessment of Liver Cancer
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7720303/
https://ncbi.nlm.nih.gov/pubmed/33329759
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756284820977693
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky